24 May 2013
Keywords: further, evidence, memantine, efficacy, dementia, results, phase
Article | 05 March 1999
Results of a Phase III trial of Merz & Co's dementia drug Akatinol(memantine) suggest that the drug may improve the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
23 May 2013
© 2013 thepharmaletter.com